Results 41 to 50 of about 21,210 (293)
Encephalopathy and Endophthalmitis Following Device-Related Invasive <i>Clavispora Lusitaniae</i> Infection in an Immunocompetent Patient: A Case Report. [PDF]
Clin Case RepABSTRACT Device‐related Candida infections are becoming more prevalent, even among immunocompetent individuals. For patients diagnosed with invasive candidiasis, it is essential to perform a fundoscopic examination, irrespective of the presence of ocular symptoms.
Cui Y +13 more
europepmc +2 more sources
Combined antifungal resistance and biofilm tolerance: the global threat of Candida auris [PDF]
, 2019 The enigmatic yeast Candida auris has emerged over the last decade and rapidly penetrated our consciousness. The global threat from this multidrug-resistant yeast has generated a call to arms from within the medical mycology community.
Kean, Ryan, Ramage, Gordon
core +2 more sources
Rapid Detection of Echinocandins Resistance by MALDI-TOF MS in Candida parapsilosis Complex
Microorganisms, 2020 Mass spectrometry by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) was used to identify and differentiate the pattern of susceptibility of clinical isolates of Candida parapsilosis complex. 17 C.
Ana Emília M Roberto +5 more
semanticscholar +1 more source
Antimicrobial activity, synergism and inhibition of germ tube formation by Crocus sativus-derived compounds against Candida spp [PDF]
, 2016 The limited arsenal of synthetic antifungal agents and the emergence of resistant Candida strains have prompted the researchers towards the investigation of naturally occurring compounds or their semisynthetic derivatives in order to propose new ...
ANGIOLELLA, Letizia +4 more
core +2 more sources
Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside
Antimicrobial Agents and Chemotherapy, 2019 Echinocandins (caspofungin, micafungin, anidulafungin), targeting β-1,3-glucan synthesis of the cell wall, represent one of the three currently available antifungal drug classes for the treatment of invasive fungal infections.
M. Aruanno, E. Glampedakis, F. Lamoth
semanticscholar +1 more source
Stimulation of chitin synthesis rescues Candida albicans from echinocandins.
PLoS Pathogens, 2008 Echinocandins are a new generation of novel antifungal agent that inhibit cell wall beta(1,3)-glucan synthesis and are normally cidal for the human pathogen Candida albicans. Treatment of C.
Louise A Walker +5 more
doaj +1 more source
Candida auris, what do paediatricians need to know? [PDF]
, 2018 AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core +1 more source
Journal of Clinical Pharmacy and Therapeutics, 2020 Anidulafungin, caspofungin and micafungin are three widely used echinocandin drugs licensed for the treatment of invasive fungal infections, and their clinical use is widespread.
Xiaoqing Liu +3 more
semanticscholar +1 more source
Journal of Fungi, 2021 This study was designed to analyze the interaction of 21 antifungal combinations consisting of seven major antifungal agents against 11 echinocandin- susceptible and six-resistant C. glabrata isolates. The combinations were divided into five major groups
Hazim O. Khalifa +3 more
doaj +1 more source
Fungal biofilm resistance [PDF]
, 2012 Fungal biofilm infections have become increasingly recognised as a significant clinical problem. One of the major reasons behind this is the impact that these have upon treatment, as antifungal therapy often fails and surgical intervention is required ...
Rajendran, Ranjith +3 more
core +4 more sources